Yep, the addressable population in Pitt Hopkins is smaller than Phelan-McDermid, but the effect of having 2 successful trials with the same drug more than makes up for that imo.
I don't know about others here, but I got enough on the line here to be nervous. Confident, but definately buzzing.
Good luck everyone.
Yep, the addressable population in Pitt Hopkins is smaller than...
-
- There are more pages in this discussion • 1,209 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.47 |
Change
-0.280(1.78%) |
Mkt cap ! $2.001B | |||
| Open | High | Low | Value | Volume |
| $15.88 | $15.93 | $15.41 | $4.496M | 287.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 4431 | $16.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.93 | 2050 | 1 |
View Market Depth
| Last trade - 15.59pm 28/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |